Chinese english Germany Japanese Korea

1-Methylindoline-4-carboxylic acid

1-Methylindoline-4-carboxylic acid Struktur
168899-63-6
CAS-Nr.
168899-63-6
Englisch Name:
1-Methylindoline-4-carboxylic acid
Synonyma:
1-Methylindoline-4-carboxylic acid;1H-Indole-4-carboxylic acid, 2,3-dihydro-1-methyl-
CBNumber:
CB92616936
Summenformel:
C10H11NO2
Molgewicht:
177.2
MOL-Datei:
168899-63-6.mol
Request For Quotation

1-Methylindoline-4-carboxylic acid Eigenschaften

Siedepunkt:
365.9±35.0 °C(Predicted)
Dichte
1.246±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
pka
2.95±0.20(Predicted)

Sicherheit

1-Methylindoline-4-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Methylindoline-4-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-Methylindoline-4-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 40)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alchem Pharmtech,Inc. 		8485655694
sales@alchempharmtech.com United States 63711 58
KARMEL TECHNOLOGY (HK) CO.,LIMITED 		+8618795957998
 karmelhk@126.com CHINA 2886 58
Aladdin Scientific 		+1-+1(833)-552-7181
sales@aladdinsci.com United States 52927 58
Amadis Chemical Company Limited 		571-89925085
sales@amadischem.com China 131980 58
Wuhan TCASChem Technology Co., Ltd. 027-027-86697669 13986148687
 sales@tcaschem.com China 3785 55
Chengdu AstaTech Trading Co., Ltd./AstaTech (Chengdu) Pharma. Co., Ltd. +86-28-85122536 85324413
market@astatech.cn China 8033 55
Shanghai CR Corporation Limited 4006653949
 fred.wen@crcorporation.cn China 10066 58
Hangzhou Molcore Biopharmatech Co.,Ltd 400-711-5280 86-571-81025280
sales@molcore.com China 9974 58
Sichuan BaiPeng Biotechnology Co., Ltd. 028-65791793 18140026355
 568470422@qq.com China 9994 58
Wuxi AppTec 022-59987777 13552403979
 jia_guoqiang@wuxiapptec.com China 22346 58
  • 1-Methylindoline-4-carboxylic acid
  • 1H-Indole-4-carboxylic acid, 2,3-dihydro-1-methyl-
  • 168899-63-6
Copyright 2019 © ChemicalBook. All rights reserved